Northern Lincolnshire Shared Care Guidelines

These are the Shared Care Guidelines for Northern Lincolnshire. These demonstrate how the patient transition between secondary and primary care settings will take place and how correct stabilisation, monitoring and prescribing will take place to improve the outcome for patients. There will also be guidance on the structure of the interface between primary care administrated by the North Lincolnshire and the North East Lincolnshire Clinical Commissioning Groups and secondary care administrated by the Northern Lincolnshire and Goole NHS Foundation Trust.


Shared Care Guideline for the Treatment of Inflammatory Bowel Disease with Azathioprine or 6-Mercaptopurine in Adult Patients (DCM596) (North Lincolnshire AND North East Lincolnshire).


Ranolazine Prescribing Guidance

Endocrine Shared Care Guidelines

Ibandronate for post-menopausal women with breast cancer

Ibandronate for metastatic bone disease

Shared Care Guidelines for Rheumatic Diseases



Sodium Aurothiomalate


Shared Care Guidelines for Dermatology and Rheumatology

Azathioprine SCF immunosuppression in Dermatology and Rheumatology

Methotrexate SCF immunosuppression in Dermatology and Rheumatology

Shared Care Guidelines from NAVIGO (North East Lincolnshire)

Primary Care Guidance for the Management of Anxiety in Adults – V6

Guideline for prescribing and monitoring of anticonvulsants used as mood stabilisers – V1.4

Shared care guideline for the prescribing of oral antipsychotics – V7.0

Shared Care Guideline for Antipsychotic Depot Injections (Adults) – V5.0

Shared Care Guidelines for the Prescribing and Monitoring of Lithium – V8.0